SHILPAMED — Shilpa Medicare Share News
0.000.00%
Last trade - 00:00- IN₹184.31bn
- IN₹189.99bn
- IN₹15.39bn
Brief: Shilpa Medicare Receives Initial Authorization For Rotigotine Transdermal Patch From Europe
Brief: Shilpa Medicare Announces Launch Of Noducatm In India
Brief: Shilpa Medicare Sept-Quarter Consol Net PAT 440.7 Million Rupees
Brief: Shilpa Medicare Announces Positive Phase 3 Results For Oeris
Brief: Shilpa Medicare To Sell 31% Stake In Sravathi
India's Shilpa Medicare gains after European regulatory nod for anti-blood-clot drug
India's Shilpa Medicare rises as unit inks JV with Saudi firm PPI
Brief: Shilpa Medicare June-Quarter Consol Net PAT 468.9 Mln Rupees
India's Shilpa Medicare gains on profit surge
Brief: Shilpa Medicare To Consider Issue Of Bonus Shares
Brief: Shilpa Medicare Unit To Invests $2 Million In Alveolus Bio
Brief: Shilpa Medicare Unit VI Receives EIR From USFDA
India's Shilpa Medicare jumps after FDA clears Bengaluru unit
India's Shilpa Medicare rises on Saudi clearance for Bengaluru facility
Brief: Shilpa Medicare Says Shilpa Pharma Lifesciences Unit-1 Completed GMP Inspection From Anvisa
Obtain Favorable Decision In Patent Infringement Litigation Related To Lenvatinib In The U.S.
India's Shilpa Medicare falls after Q4 profit dips
Brief: Shilpa Medicare Says Shilpa Pharma Lifesciences Unit-1 Receives EIR From USFDA
Brief: Shilpa Medicare Says Unit VI Receives GMP Approval From EMA